<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04205760</url>
  </required_header>
  <id_info>
    <org_study_id>19-136</org_study_id>
    <nct_id>NCT04205760</nct_id>
  </id_info>
  <brief_title>Preoperative Nutritional Optimization and Physical Exercise for Patients Scheduled for Elective Implantation for a Left-Ventricular Assist Device</brief_title>
  <acronym>PROPER-LVAD</acronym>
  <official_title>Preoperative Nutritional Optimization and Physical Exercise for Patients Scheduled for Elective Implantation for a Left-Ventricular Assist Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot, randomized, multicenter interventional trial of a combined preoperative oral
      nutritional support (ONS) and physical exercise therapy in patients planned for elective
      implantation of a left-ventricular assist device (LVAD). This pilot study pursues to
      demonstrate the feasibility and safety of a study protocol to optimize the patients'
      nutritional and physical state to reduce the number of postoperative complications and
      consequently to ameliorate the patients' outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The oral nutrition supplementation will be started immediately after randomization and will
      be continued until surgery. The patients will receive a dosage of ONS adjusted to their
      nutritional risk. Regular monitoring of blood sugars, electrolytes, phosphate, and
      triglycerides will occur twice per week, as per standard protocol.

      In-bed cycling will be started as soon as possible after randomization. Cycling sessions will
      be performed daily for 50 minutes, at least 5 times a week until surgery. Standard safety
      criteria will be assessed prior to initiating cycling treatments. The in-bed cycling will be
      performed passively or actively with graded increasing resistance. All cycling interventions
      will be performed under 1:1 supervision of medically trained study personnel while monitoring
      patient's heart rate, systolic and diastolic blood pressure and transcutaneous oxygen
      saturation of blood.

      When evaluating the effect of a combined nutritional and exercise intervention, other
      important co-interventions should be standardized to reduce potential confounding of trial
      outcomes. All study patients should be fed with an oral diet that is in accordance to local
      standards, whereas it is strongly recommended to adhere to current clinical practice
      guidelines. Besides, the investigators highly encourage daily respiratory therapy in both
      groups plus mobilization as much as feasible.

      All other key interventions during preoperative treatment will be standardized in accordance
      to the local clinical practice. Study teams will follow up on the patients on a daily base,
      documenting adherence with study interventions and key co-interventions.

      Patients in the control group will not receive preoperative ONS. No bed cycling will be
      allowed from admission until surgery. Neither of these practices are the current standard of
      care in the participating unit.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 20, 2020</start_date>
  <completion_date type="Anticipated">June 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 20, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>National multicenter two-group randomized-controlled, blinded to assessor clinical pilot trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>functional outcome assessor will be blinded to study group allocation</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of adverse events</measure>
    <time_frame>up to 2 weeks before surgery</time_frame>
    <description>adverse events between groups related to cycling and nutritional complications</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Separation of caloric supplementation</measure>
    <time_frame>up to 2 weeks before surgery</time_frame>
    <description>Separation between groups on prescribed caloric targets</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Separation of protein supplementation</measure>
    <time_frame>up to 2 weeks before surgery</time_frame>
    <description>Separation between groups on prescribed protein targets</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of interventions received as prescribed</measure>
    <time_frame>up to 2 weeks before surgery</time_frame>
    <description>Proportion of interventions received as prescribed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of patients recruited per month</measure>
    <time_frame>up to 18 months</time_frame>
    <description>Target: 1.5 patients per month</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ratio of control patients received physiotherapy</measure>
    <time_frame>up to 2 weeks before surgery</time_frame>
    <description>Ratio of control patients received physiotherapy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ratio of control patients received nutritional support</measure>
    <time_frame>up to 2 weeks before surgery</time_frame>
    <description>Ratio of control patients received nutritional support</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>mortality rates at day 30</measure>
    <time_frame>day 30 after randomization</time_frame>
    <description>mortality rates at day 30</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rates of ICU length of stay</measure>
    <time_frame>up to 3 months</time_frame>
    <description>rates of ICU length of stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rates of hospital length of stay</measure>
    <time_frame>up to 3 months</time_frame>
    <description>rates of hospital length of stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean duration of mechanical ventilation</measure>
    <time_frame>up to 3 months</time_frame>
    <description>Mean duration of mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of complications</measure>
    <time_frame>up to 3 months</time_frame>
    <description>Incidence of complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of infections</measure>
    <time_frame>up to 3 months</time_frame>
    <description>Incidence of infections</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Mid-arm circumference</measure>
    <time_frame>up to 6 months</time_frame>
    <description>baseline values versus follow-up values</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Muscle mass - Quadriceps thickness</measure>
    <time_frame>up to 6 months</time_frame>
    <description>ultrasound, baseline values versus follow-up values</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Muscle mass - Quadriceps cross sectional area</measure>
    <time_frame>up to 6 months</time_frame>
    <description>ultrasound, baseline values versus follow-up values</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Muscle strength - Handgrip strength</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Dynamometry, baseline values versus follow-up values</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Muscle strength - Quadriceps strength</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Dynamometry, baseline values versus follow-up values</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Clinical Frailty score (CFS)</measure>
    <time_frame>up to 6 months</time_frame>
    <description>baseline values versus follow-up values; Score: 1-9 (very fit: 1, terminally ill: 9)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Physical function - 6-Minute Walk Test</measure>
    <time_frame>up to 6 months</time_frame>
    <description>baseline values versus follow-up values, 6-minute walking distance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Physical function - Short Physical Performance Battery</measure>
    <time_frame>up to 6 months</time_frame>
    <description>baseline values versus follow-up values,(Score: 0-12; 0=worst performance and 12=best performance)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Physical function - Functional Status Score for the ICU</measure>
    <time_frame>up to 6 months</time_frame>
    <description>baseline values versus follow-up values,(Score 0-35; the higher the score, the better physical functioning)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life - Lawton Instrumental Activities of Daily Living (IADL)</measure>
    <time_frame>up to 6 months</time_frame>
    <description>baseline values versus follow-up values, (score 0-8; the higher the more independent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life - Katz Activities of Daily Living (ADL)</measure>
    <time_frame>up to 6 months</time_frame>
    <description>baseline values versus follow-up values,(Score: 0-100; the higher the more independent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life - Short Form 36 (SF-36)</measure>
    <time_frame>up to 6 months</time_frame>
    <description>baseline values versus follow-up values,(Score: 0-100; 100=no limitation in daily life and 0=completely limited)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in neurological function - Mini Mental State Examination</measure>
    <time_frame>up to 6 months</time_frame>
    <description>baseline values versus follow-up values, (score: 0-30; the higher the less cognitively impaired)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Left Ventricular Assist Device</condition>
  <condition>End-stage Heart Failure</condition>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard Care as per local guidelines</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral nutrition support (ONS) and bed-cycling before surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Nutrition + exercise</intervention_name>
    <description>Patients will receive preoperative optimization consisting of oral nutrition support (Fresubin 3.2 kcal) and bed-cycling (50 minutes per day) for 5-14 days before surgery.</description>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>bed cycling</other_name>
    <other_name>ONS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Given informed consent

          2. Adult patients (â‰¥18 years)

          3. Patients undergoing elective LVAD implantation Additional cardiac surgery, such as
             bypass grafting, or valve repair is permitted

        Exclusion Criteria:

          1. Hospital admission &lt;5 days prior to planned LVAD implantation

          2. Patients on ECMO or INTERMACS&lt;1

          3. Patients already receiving nutrition support on hospital admission

          4. Enteral nutrition is contraindicated.

          5. Pregnant or lactating patients

          6. Patients with clinical fulminant hepatic failure

          7. Patients with cirrhosis Child's Class C Liver Disease

          8. Patients with clinical kidney failure or requiring hemodialysis

          9. Known allergy or intolerance to study nutrients

         10. Intracranial or spinal process affecting motor function

         11. Lower extremity impairments that prevent cycling

         12. Disabling neuropsychiatric disorders or language barriers

         13. Weight &gt; 150 kg

         14. Enrolment in an industry sponsored randomized trial within the last 30 days
             (co-enrolment in academic randomized trials will be considered on a case by case
             basis)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Stoppe, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>RWTH Aachen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aileen Hill, Dr. med.</last_name>
    <phone>+49 241 80</phone>
    <phone_ext>38166</phone_ext>
    <email>ahill@ukaachen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elena Laaf, MSc</last_name>
    <phone>+49 241 80</phone>
    <phone_ext>89021</phone_ext>
    <email>elaaf@ukaachen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>RWTH Aachen University</name>
      <address>
        <city>Aachen</city>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Aileen Hill, Dr. med.</last_name>
    </contact>
    <contact_backup>
      <last_name>Elena Laaf, MSc</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Heart Center Dresden</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Klaus Matschke, Univ.-Prof. Dr. med. habil.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Justus-Liebig University Giessen</name>
      <address>
        <city>Giessen</city>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Bernd Niemann, PD Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Schleswig-Holstein, Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Bernd Panholzer, Dr. med.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>December 18, 2019</study_first_submitted>
  <study_first_submitted_qc>December 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2019</study_first_posted>
  <last_update_submitted>March 10, 2020</last_update_submitted>
  <last_update_submitted_qc>March 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>RWTH Aachen University</investigator_affiliation>
    <investigator_full_name>Christian Stoppe</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>LVAD</keyword>
  <keyword>preoperative optimization</keyword>
  <keyword>end-stage heart failure</keyword>
  <keyword>cardiac surgery</keyword>
  <keyword>nutrition therapy</keyword>
  <keyword>exercise</keyword>
  <keyword>cycling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

